April 16, 2026
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: Early studies identify a new treatment for E coli infections
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Drug development > Early studies identify a new treatment for E coli infections
Drug development

Early studies identify a new treatment for E coli infections

By Newsroom
Last updated: April 5, 2025
1 Min Read
Share


Scientists have taken an important step toward the development of a potential new treatment for treating Shiga toxin-producing E coli (STEC), the bacteria associated with severe food poisoning. 

The findings – led by the University of Glasgow and published in Antimicrobials and Resistance – demonstrate, for the first time, the use of an antivirulence drug called Aurodox, a potential alternative to traditional antibiotic treatment, to be an effective treatment when used in mice models of…



Source link

TAGGED:AntivirulenceBacteriagut microbiomeMouse modelsPreclinical developmentUniversity of Glasgow
Share This Article
Facebook Email Copy Link Print

HOT NEWS

Key Takeaways from CANECT 2025

Environmental Science
June 6, 2025

Data-driven manufacturing and case management in autologous…

Autologous therapies need data-driven manufacturing and supply chain mastery. Integrated CDMOs combine both functions to…

April 16, 2026

تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك

California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…

April 5, 2025

Arab Newswire Provides Press Release Distribution in Arabic

Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…

April 5, 2025

YOU MAY ALSO LIKE

Resistance to change still greatest barrier to AI drug discovery

Resistance to change has emerged as the biggest barrier (51%) to data innovation in the pharmaceutical industry, while lack of…

Drug development
April 5, 2025

SDTM data transformation with Pinnacle 21

Mapping clinical data to CDISC SDTM is mandatory for clinical trial submissions. But accurately mapping to SDTM is increasingly complex…

Drug development
October 26, 2025

Isomorphic Labs raises $600m to support AI drug design

Isomorphic Labs has raised $600 million towards its ambition to leverage AI to reimagine and accelerate drug discovery.  The financing round…

Drug development
April 5, 2025

QSP Modeling | Preclinical Radiopharmaceuticals Development

The preclinical-to-clinical transition remains a major bottleneck for targeted radiotherapies due to their complexity and novelty. Traditional dosimetry translation methods…

Drug development
November 16, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

Data-driven manufacturing and case management in autologous…
April 16, 2026
Strategic Synergy: Integrating Medical Affairs and Commercial…
April 15, 2026
How to make scalability your strategic advantage
April 15, 2026
Redefining Type 1 Diabetes Treatment with Cell and Gene…
April 15, 2026

Life Science Magazines

Data-driven manufacturing and case management in autologous…
April 16, 2026
Strategic Synergy: Integrating Medical Affairs and Commercial…
April 15, 2026
How to make scalability your strategic advantage
April 15, 2026
Redefining Type 1 Diabetes Treatment with Cell and Gene…
April 15, 2026

LS Newswire Service™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?